Methamphetamine P NH2 Antikörper

Produktnummer ABIN487758

Der Schaf Polyklonal anti-Methamphetamine P NH2 Antikörper wird verwendet zum Nachweis von Methamphetamine P NH2. Er wurde validiert für EIA.

Kurzübersicht für Methamphetamine P NH2 Antikörper (ABIN487758)

Target: Methamphetamine P NH2

Wirt: Schaf

Klonalität: Polyklonal

Applikation: Enzyme Immunoassay (EIA)

Produktdetails

Aufreinigung: Ig Fraction

Immunogen: Methamphetamine (p)-BSA

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: ELISA: , 2.5 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 9.72mg/mL (U.V. abs at 280nm)

Buffer: 20 mM Phosphate, 150 mM Sodium Chloride, pH 7.2 containing 0.09 % Sodium Azide as preservative

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: -20 °C

Antigendetails

Target: Methamphetamine P NH2

Andere Bezeichnung: Methamphetamine (P)

Substanzklasse: Chemical

Hintergrund: Methamphetamine (METH) is closely related chemically to amphetamine (AMPH). METH is a potent central nervous system stimulant with additional peripheral sympathomimetic effects. METH and AMPH have been used clinically in the treatment of obesity, minimal brain dysfunction, narcolepsy, depression and to counter fatigue. They are also subjected to widespread abuse. METH is an indirect agonists. It causes the release of newly synthesized norepinephrine and dopamine and it blocks the re uptake of these transmitters from the synapse. This can lead to an increase in the concentration of catecholamines in the synapse as well as an overall increase in catecholaminergic activity in the brain. The mechanism of METH induced neurotoxicity for all monoaminergic cell types may lie primarily with the dopaminergic system in the striatum. It may also lie with the interaction between METH induced release of dopamine and its ability to inhibit monoamine oxidase.Synonyms: METH